Clinical Trial Update: SREBF1 Polymorphism and Egg Yolk on Cardiovascular Disease Risk in Healthy Young Adults: a Randomised, Two-period, Single Blinded, Crossover Trial [NA]

View source ↗

Summary

The clinical trial evaluating SREBF1 polymorphism and egg yolk effects on cardiovascular disease risk in healthy young adults is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Shandong University | Conditions: Healthy, GEN1 Gene Mutation | NA | Status: SUSPENDED